Equity · Healthcare
BRKR
Bruker Corporation · NasdaqGS
The line runs $57 on 18 June through $55.75 on 15 September, on a scale from $50 to $65. Days the market did not trade hold the previous close, flat.
The chart above plots the price of BRKR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $57 on 18 June 2026 through $55.75 on 15 September 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 16, 2026
BRKR insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 21 compensation filings in this window. The figures above count all of them.
BRKR reported financials
BRKR reported revenue of $3.4B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$8.6M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
BRKR earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
BRKR institutional holders
8 of the 45 institutional funds we track reported a BRKR position for the quarter ended 30 Jun 2026 — a combined $252.6M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
BRKR fails-to-deliver
On 31 Aug 2026, 15,657 shares of BRKR failed to deliver (about $894K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data